Trimble Navigation Reaches New 52-Week High (TRMB)

NEW YORK ( TheStreet) -- Trimble Navigation (Nasdaq: TRMB) hit a new 52-week high Tuesday as it is currently trading at $55.23, above its previous 52-week high of $55 with 552,894 shares traded as of 12:05 p.m. ET. Average volume has been 570,000 shares over the past 30 days.

Trimble Navigation has a market cap of $5.55 billion and is part of the technology sector and electronics industry. Shares are up 26.4% year to date as of the close of trading on Monday.

Trimble Navigation Limited provides positioning, wireless, and software technology solutions. The company has a P/E ratio of 45, above the average electronics industry P/E ratio of 35.4 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Trimble Navigation as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full Trimble Navigation Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus